- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Immune checkpoint inhibitors for metastatic uveal melanoma: a meta-analysis ; volume:14 ; number:1 ; day:3 ; month:4 ; year:2024 ; pages:1-11 ; date:12.2024
Scientific reports ; 14, Heft 1 (3.4.2024), 1-11, 12.2024
- Creator
-
Yamada, Kayoko
Takeuchi, Masaki
Fukumoto, Takeshi
Suzuki, Minako
Kato, Ai
Mizuki, Yuki
Yamada, Norihiro
Kaneko, Takeshi
Mizuki, Nobuhisa
Horita, Nobuyuki
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-55675-5
- URN
-
urn:nbn:de:101:1-2406190934413.321010764793
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:56 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Yamada, Kayoko
- Takeuchi, Masaki
- Fukumoto, Takeshi
- Suzuki, Minako
- Kato, Ai
- Mizuki, Yuki
- Yamada, Norihiro
- Kaneko, Takeshi
- Mizuki, Nobuhisa
- Horita, Nobuyuki
- SpringerLink (Online service)
Other Objects (12)
Is there a role for immune checkpoint blockade in metastatic uveal melanoma?
Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study
Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study
Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Re-Induction following Resistance or Toxicity
The Role of Immune Checkpoint Blockade in Uveal Melanoma
Novel treatment paradigms for metastatic uveal melanoma
Detection of neoplastic-immune hybrid cells with metastatic properties in uveal melanoma
The immune cell landscape of metastatic uveal melanoma correlates with overall survival
Optimizing immune checkpoint blockade in metastatic uveal melanoma: exploring the association of overall survival and the occurrence of adverse events
Immune checkpoint blockade for metastatic uveal melanoma: patterns of response and survival according to the presence of hepatic and extrahepatic metastasis
Pembrolizumab as first-line treatment for metastatic uveal melanoma
Immune checkpoint inhibitor triggered parkinsonism in a patient with metastatic melanoma
Is there a role for immune checkpoint blockade in metastatic uveal melanoma?
Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study
Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study
Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Re-Induction following Resistance or Toxicity
The Role of Immune Checkpoint Blockade in Uveal Melanoma
Novel treatment paradigms for metastatic uveal melanoma
Detection of neoplastic-immune hybrid cells with metastatic properties in uveal melanoma
The immune cell landscape of metastatic uveal melanoma correlates with overall survival
Optimizing immune checkpoint blockade in metastatic uveal melanoma: exploring the association of overall survival and the occurrence of adverse events
Immune checkpoint blockade for metastatic uveal melanoma: patterns of response and survival according to the presence of hepatic and extrahepatic metastasis
Pembrolizumab as first-line treatment for metastatic uveal melanoma
Immune checkpoint inhibitor triggered parkinsonism in a patient with metastatic melanoma
Is there a role for immune checkpoint blockade in metastatic uveal melanoma?
Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study
Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study
Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Re-Induction following Resistance or Toxicity
The Role of Immune Checkpoint Blockade in Uveal Melanoma
Novel treatment paradigms for metastatic uveal melanoma
Detection of neoplastic-immune hybrid cells with metastatic properties in uveal melanoma
The immune cell landscape of metastatic uveal melanoma correlates with overall survival
Optimizing immune checkpoint blockade in metastatic uveal melanoma: exploring the association of overall survival and the occurrence of adverse events
Immune checkpoint blockade for metastatic uveal melanoma: patterns of response and survival according to the presence of hepatic and extrahepatic metastasis
Pembrolizumab as first-line treatment for metastatic uveal melanoma